Neurosciences
New agent blocks stress response
Research
ETH Zurich
If the body’s natural stress response gets knocked off balance, it can result in physical and mental health disorders. Researchers at ETH Zurich have developed an agent capable of selectively inhibiting this response.
Clarifying the cause of Guillain-Barré Syndrome
Research
ETH Zurich
Guillain-Barré Syndrome is a rare condition in which a person’s immune system attacks the peripheral nerves. People affected suffer from muscle weakness and paralysis. A research team led by ETH Zurich has now clarified the mechanism of this autoimmune disease.
Methods for bypassing and treating spinal cord injury
TechTransfer
EPFL
Grégoire Courtine, Jocelyne Bloch and their research team have been breaking new ground in the treatment of neurological disorders for over a decade. Here’s a look at some of the promising new therapies they’ve developed.
More parallel 'traffic' observed in human brains than in animals
Research
EPFL
In a study comparing human brain communication networks with those of macaques and mice, EPFL researchers found that only the human brains transmitted information via multiple parallel pathways, yielding new insights into mammalian evolution.
Cognitive strategies for augmenting the body an extra robotic arm
Research
EPFL
EPFL scientists show that breathing may be used to control a wearable extra robotic arm in healthy individuals, without hindering control of other parts of the body.
Riding sound waves in the brain
Research
ETH Zurich
ETH Zurich researchers have shown for the first time that microvehicles can be steered through blood vessels in the brains of mice using ultrasound. They hope that this will eventually lead to treatments capable of delivering drugs with pinpoint precision.
Page 5 of 16